当前位置:首页 - 行情中心 - 国邦医药(605507) - 财务分析 - 现金流量表

国邦医药

(605507)

  

流通市值:68.70亿  总市值:127.24亿
流通股本:3.02亿   总股本:5.59亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,548,798,584.272,357,214,060.331,014,845,497.664,297,122,523.75
  收到的税费返还128,316,189.9580,357,131.1552,017,213.95132,326,467.68
  收到其他与经营活动有关的现金66,925,845.556,242,913.1916,655,521.74144,873,277.11
  经营活动现金流入小计3,744,040,619.722,493,814,104.671,083,518,233.354,574,322,268.54
  购买商品、接受劳务支付的现金2,453,822,341.51,795,171,004.81,079,851,125.732,735,581,861.01
  支付给职工以及为职工支付的现金490,575,169.08327,760,147197,242,475.93578,084,023.2
  支付的各项税费195,722,975.86140,537,743.7562,596,171.06180,478,366.51
  支付其他与经营活动有关的现金198,409,764.58127,468,322.5295,500,225.15373,767,161.97
  经营活动现金流出小计3,338,530,251.022,390,937,218.071,435,189,997.873,867,911,412.69
  经营活动产生的现金流量净额405,510,368.7102,876,886.6-351,671,764.52706,410,855.85
二、投资活动产生的现金流量:
  收回投资收到的现金11,204,886,910.377,885,644,647.395,229,382,217.245,305,845,381.22
  取得投资收益收到的现金12,908,614.84,275,341.242,731,700.31-
  处置固定资产、无形资产和其他长期资产收回的现金净额17,391,741.167,000-17,957,075.09
  投资活动现金流入小计11,235,187,266.337,889,926,988.635,232,113,917.555,323,802,456.31
  购建固定资产、无形资产和其他长期资产支付的现金267,111,860.66156,529,256.8241,094,271.9419,124,791.01
  投资支付的现金11,480,494,000.277,960,494,000.275,350,194,0005,418,523,627.77
  支付其他与投资活动有关的现金--2,800,000-
  投资活动现金流出小计11,747,605,860.938,117,023,257.095,394,088,271.95,837,648,418.78
  投资活动产生的现金流量净额-512,418,594.6-227,096,268.46-161,974,354.35-513,845,962.47
三、筹资活动产生的现金流量:
  吸收投资收到的现金---580,000
  其中:子公司吸收少数股东投资收到的现金---580,000
  取得借款收到的现金912,045,385.23846,045,385.23560,269,185.23593,210,874.79
  收到其他与筹资活动有关的现金---97,112,950
  筹资活动现金流入小计912,045,385.23846,045,385.23560,269,185.23690,903,824.79
  偿还债务支付的现金727,697,125.14633,662,888.89281,290,000782,290,120
  分配股利、利润或偿付利息支付的现金349,819,137.69344,835,327.455,433,572.24194,101,417.33
  支付其他与筹资活动有关的现金109,651,422.94109,651,422.947,040,773.09101,006,281.88
  筹资活动现金流出小计1,187,167,685.771,088,149,639.28293,764,345.331,077,397,819.21
  筹资活动产生的现金流量净额-275,122,300.54-242,104,254.05266,504,839.9-386,493,994.42
四、汇率变动对现金及现金等价物的影响3,233,366.234,476,304.155,105,660.3927,075,876.71
五、现金及现金等价物净增加额-378,797,160.21-361,847,331.76-242,035,618.58-166,853,224.33
  加:期初现金及现金等价物余额1,534,371,563.841,534,371,563.841,534,371,563.841,701,224,788.17
  期末现金及现金等价物余额1,155,574,403.631,172,524,232.081,292,335,945.261,534,371,563.84
补充资料:
  净利润-453,993,510.87-780,577,499.03
  资产减值准备-5,687,697.17-25,825,347.98
  固定资产和投资性房地产折旧-230,242,062.94-421,900,844.05
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-230,242,062.94-417,995,572.93
    投资性房地产折旧---3,905,271.12
  无形资产摊销-5,446,297.32-11,478,959.41
  长期待摊费用摊销-234,994.86-574,634.78
  处置固定资产、无形资产和其他长期资产的损失-453,560.93-9,107,023.5
  固定资产报废损失-1,207,798.27-6,539,309.02
  公允价值变动损失--8,941,286.24--14,402,252.11
  财务费用-20,608,127.14-203,310.09
  投资损失--3,963,177.2--12,948,302.52
  递延所得税--4,177,204.33--5,309,169.4
  其中:递延所得税资产减少--3,570,285.87--1,181,223.33
    递延所得税负债增加--606,918.46--4,127,946.07
  存货的减少--126,321,351.77--20,679,871.5
  经营性应收项目的减少--357,735,423.44--634,306,006.95
  经营性应付项目的增加--126,929,146.53-120,727,393.38
  其他-4,736,965.32-4,873,863.47
  现金的期末余额-1,172,524,232.08-1,534,371,563.84
  减:现金的期初余额-1,534,371,563.84-1,701,224,788.17
  现金及现金等价物的净增加额--361,847,331.76--166,853,224.33
公告日期2025-10-172025-07-302025-04-162025-03-28
审计意见(境内)标准无保留意见
TOP↑